The Doctor’s Advocate
Second Quarter 2025 | ArchivesIndustry and Company News
The Doctors Company Announces Acquisition of ProAssurance
The Doctors Company to Acquire ProAssurance
The Doctors Company has entered into a definitive agreement to acquire ProAssurance, an industry-leading specialty insurer with extensive expertise in medical professional liability and products liability for medical technology and life sciences. The combined company will have assets of approximately $12 billion.
“We are excited to further our mission to advance, protect, and reward the practice of good medicine to an even greater number of healthcare providers across the nation,” said Richard E. Anderson, MD, FACP, Chairman and Chief Executive Officer of The Doctors Company. “Healthcare is a team sport and the teams are getting larger. In order to provide them the best imaginable service requires a mission-based company with nationwide scale, resources, and dedication to all medical professions and healthcare providers. The addition of ProAssurance to The Doctors Company significantly enhances our ability to serve healthcare professionals now and well into the future.”
The Doctors Company Announces $15.1 Million Dividend
The Doctors Company has approved a 2025 premium dividend of approximately $15.1 million, bringing the total of declared dividends to date to $485 million. Dividends of up to 10 percent were approved by The Doctors Company Board of Governors for eligible members in the following states: Florida, Idaho, Illinois, Maryland, Massachusetts, Michigan, Montana, North Carolina, Ohio, Oregon, Texas, Virginia, Washington, and Wyoming. Members of the American Society of Plastic Surgeons® may also receive a dividend, depending on their eligibility.
Eligible members will receive this year’s dividend on their annual premium for policy renewals between July 1, 2025, and June 30, 2026.
TDC Group Experts Predict What Healthcare Will Look Like in 2035
Each year, TDC Group predicts emerging healthcare trends over the next decade, focusing on the challenges, risks, and opportunities that shape the industry. Our 2025 report covers the top issues facing healthcare, including nuclear malpractice verdicts, artificial intelligence, patient mistrust, and more.
The Doctors Company Promotes Laura Kline to Regional Operating Officer of the Northeast Region
Laura Kline, MBA, CPCU, CIC, has been promoted to Regional Operating Officer of the Northeast Region for The Doctors Company. In her new role, Ms. Kline will drive operational excellence across the 26 states located in the Northeast Region and lead teams including Business Development, Underwriting, Claims, and Patient Safety and Risk Management in enhancing member experiences.
Ambient Listening With AI: New Article Explores Legal and Ethical Issues
Ambient listening, which involves using artificial intelligence (AI) to record and analyze conversations between clinicians and patients, is one area of early AI adoption among healthcare professionals. In a new article published in JAMA Network Open, I. Glenn Cohen, JD; Julie Ritzman, MBA, CPHRM, Vice President, Patient Safety, The Doctors Company; and Richard F. Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, provide a comprehensive analysis of the legal and ethical considerations associated with the use of ambient listening technologies in healthcare settings.
Expert Shares 7 Mistakes to Avoid If You Get Sued
In a new article published in MedCentral, Robert E. White, Jr., President of The Doctors Company and TDC Group, shares common mistakes clinicians make when facing malpractice litigation, and strategies to avoid them.
The Doctor’s Advocate is published by The Doctors Company to advise and inform its members about loss prevention and insurance issues.
The guidelines suggested in this newsletter are not rules, do not constitute legal advice, and do not ensure a successful outcome. They attempt to define principles of practice for providing appropriate care. The principles are not inclusive of all proper methods of care nor exclusive of other methods reasonably directed at obtaining the same results.
The ultimate decision regarding the appropriateness of any treatment must be made by each healthcare provider considering the circumstances of the individual situation and in accordance with the laws of the jurisdiction in which the care is rendered.
The Doctor’s Advocate is published quarterly by Corporate Communications, The Doctors Company. Letters and articles, to be edited and published at the editor’s discretion, are welcome. The views expressed are those of the letter writer and do not necessarily reflect the opinion or official policy of The Doctors Company. Please sign your letters, and address them to the editor.
